Certified by Founder Lodge
Vicebio
United Kingdom - Londres, Angleterre, Royaume-Uni
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Vicebio uses the molecular clamp technology to develop innovative vaccines against life-threatening respiratory viruses. The Molecular Clamp technology provide unique stabilisation of viral e
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 24 ,2024 | Series B | $100,000,000 |
Goldman Sachs Asset Management
Avoro Capital Advisors
TCGX
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Poetiq | $45,800,000 | (Feb 3, 2026)
1Buy.AI | $3,900,000 | (Feb 3, 2026)
Principle | $2,000,000 | (Feb 3, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
